XRTX
XORTX Therapeutics Inc
NASDAQ: XRTX · HEALTHCARE · BIOTECHNOLOGY
$2.86
+4.76% today
Updated 2026-04-30
Market cap
$4.22M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.80
Dividend yield
—
52W range
$2 – $7
Volume
1.5M
XORTX Therapeutics Inc (XRTX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-98.00%
ROA
-46.80%
Debt/equity
0.03x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2014 | — | $-36922.00 | — | — | — |
| 2015 | — | $-279309.00 | — | — | — |
| 2016 | — | $-414834.00 | — | — | — |
| 2017 | $0.00 | $-474201.00 | — | — | — |
| 2018 | $0.00 | $-3.78M | — | — | — |
| 2019 | $0.00 | $-629576.00 | — | — | — |
| 2020 | $0.00 | $-1.28M | — | — | — |
| 2021 | $0.00 | $-1.65M | — | — | — |
| 2022 | $0.00 | $-6.99M | — | — | — |
| 2023 | $0.00 | $-2.86M | — | — | — |
| 2024 | $0.00 | $-4.54M | — | — | — |
| 2025 | $0.00 | $-3.71M | — | — | — |